A new study showing that, following external beam radiation therapy (EBRT), sexual function doesn’t continue to decline significantly after two years, contradicts some previous thinking. While other recent studies have reported that sexual function gets persistently worse after EBRT, most of these didn’t assess sexual function prior to...
News and information about prostate cancer
Researchers at the Jewish General Hospital (affiliated with McGill University) in Montreal (Québec) have uncovered a new link between two genetic pathways that curtail the growth of tumours. The discovery, made along with American colleagues, may lead to new treatments for several types of cancer, including prostate cancer.
The scientists made the...
A new class of synthetic molecules developed by scientists at Yale University (New Haven, Connecticut) enhance the ability of the body’s immune system to recognize prostate cancer cells, and might lead to a new therapeutic approach for this disease.
These antibody-recruiting molecules targeting prostate cancer (ARM-Ps) were designed to bind...
A recent study has concluded that men undergoing surgical treatment for prostate cancer have a survival benefit if the radical prostatectomy is completed, regardless of their lymph node status.
The surgical removal of one or more lymph nodes (lymph node dissection or lymphadectomy) is standard procedure during radical prostatectomy, if surgeons...
A recent clinical trial conducted at Queen’s University (Kingston, Ontario) has reported that low-dose nitroglycerin might slow or stop prostate cancer progression, without significant side effects. The small, phase II study was the first ever to provide clinical evidence for nitroglycerine as a therapy for prostate cancer.
Nitroglycerine,...
Researchers from North Carolina have discovered the first gene linked to aggressive prostate cancer. They hope their breakthrough will lead to advances in predicting which prostate cancers are likely to be indolent (grow slowly) and which will progress quickly — still one of the major challenges affecting the kind of treatment patients choose to...